₹119
▼ -1.53 -1.27%
As of 10 Sept 2026 · delayed
BSE Listed
Godavari Drugs Ltd. (530317)
Volume: 14,409Avg Vol 1W: 18,649Avg Vol 1M: 11,52652W Range:₹69.7₹135.25
Key Ratios
Checked 6h agoMarket Cap₹130 Cr
Current Price₹119
Previous Close₹120.53
High / Low (52w)₹135.25 / ₹69.7
Volume14,409
Avg Vol (1W)18,649
Avg Vol (1M)11,526
Stock P/E33.43
Book Value₹71.05
Dividend Yield0%
ROE5.39%
ROA207.55%
Revenue (TTM)—
Revenue Growth—
Profit Margin378.35%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹3.56
P/B1.67
Debt / Equity1.23
50 DMA₹109.6
200 DMA₹100.84
Day change-1.27%
Price Chart
₹119▲ 42.36% · 1Y
2025-09-102026-09-10
20-day avg volume: 12K shares
Pros
- Company is almost debt-free.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹26 Cr | ₹30 Cr | ₹26 Cr | ₹24 Cr | ₹27 Cr | ₹22 Cr | ₹33 Cr | ₹28 Cr |
| EBITDA | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| Net Profit | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹84 Cr | ₹96 Cr | ₹123 Cr | ₹161 Cr | ₹160 Cr | ₹157 Cr | ₹114 Cr | ₹107 Cr |
| EBITDA | ₹5 Cr | ₹5 Cr | ₹9 Cr | ₹10 Cr | ₹9 Cr | ₹12 Cr | ₹10 Cr | ₹9 Cr |
| Net Profit | ₹1 Cr | ₹2 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹6 Cr | ₹4 Cr | ₹4 Cr |
| EPS | 1.6 | 2.66 | 5.48 | 6.97 | 5.03 | 7.37 | 5.82 | 5.36 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹74 Cr | ₹84 Cr | ₹91 Cr | ₹101 Cr | ₹121 Cr | ₹135 Cr | ₹143 Cr | ₹200 Cr |
| Total Liabilities | ₹55 Cr | ₹64 Cr | ₹67 Cr | ₹72 Cr | ₹88 Cr | ₹96 Cr | ₹100 Cr | ₹125 Cr |
| Equity | ₹18 Cr | ₹20 Cr | ₹24 Cr | ₹30 Cr | ₹33 Cr | ₹39 Cr | ₹43 Cr | ₹76 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | ₹3 Cr | ₹13 Cr | ₹14 Cr | ₹19 Cr | ₹12 Cr | ₹2 Cr |
| Investing | ₹-1 Cr | ₹-5 Cr | ₹-9 Cr | ₹-13 Cr | ₹-20 Cr | ₹-26 Cr |
| Financing | ₹0 Cr | ₹-6 Cr | ₹-4 Cr | ₹-6 Cr | ₹8 Cr | ₹37 Cr |
| Free Cash Flow | ₹3 Cr | ₹13 Cr | ₹14 Cr | ₹19 Cr | ₹12 Cr | ₹2 Cr |
Shareholding
Promoter 40.23% Institutions 2.74% Public 57.03%
Efficiency & Working Capital
ROCE5.9%
Interest Coverage2.3
Dividend Payout—
Debtor Days150 d
Inventory Days159 d
Payable Days120 d
Cash Conversion Cycle189 d
Working Capital Days309 d
Shareholding Details
As of 2026-06-30
Promoter40.2%
FII0%
DII2.7%
Institutions2.7%
Public57%
Promoter Pledge0.2%
No. of Shareholders6,722
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 53.2% | 53.2% | 53.2% | 53.2% | 52.6% | 52.6% | 52.6% | 52.6% | 52.6% | 52.6% | 40.2% | 40.2% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 2.5% | 2.7% |
| Public | 46.3% | 46.3% | 46.3% | 46.3% | 46.9% | 46.9% | 46.9% | 46.9% | 46.9% | 46.9% | 57.3% | 57% |
| Promoter Pledge | 1.3% | 1.3% | 1.3% | 1.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% |
| No. of Shareholders | 7,019 | 6,894 | 7,005 | 7,044 | 7,709 | 7,915 | 7,881 | 7,828 | 7,720 | 7,483 | 7,300 | 6,722 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Sushma Kakani | Shareholding of Promoter and Promoter Group | 11.4% | 11,55,000 |
| Kamala Jaju | Shareholding of Promoter and Promoter Group | 9% | 9,10,000 |
| Mohit Jaju | Shareholding of Promoter and Promoter Group | 5.3% | 5,35,000 |
| Ghanshyam Jaju | Shareholding of Promoter and Promoter Group | 3.5% | 3,50,000 |
| Mukund Kakani | Shareholding of Promoter and Promoter Group | 3.5% | 3,50,000 |
| Aksheit Kakani | Shareholding of Promoter and Promoter Group | 3.2% | 3,26,000 |
| Sachin Kasera | Public Shareholding | 2.2% | 2,24,725 |
| Suryatej Advisors Llp | Public Shareholding | 2.2% | 2,24,725 |
| Highcrestt Global Company Ltd | Public Shareholding | 2% | 2,00,000 |
| Priyanka Jaju | Shareholding of Promoter and Promoter Group | 1.8% | 1,85,000 |
| Ketan V Thakkar | Public Shareholding | 1.7% | 1,68,540 |
| Umesh Kumar Gupta | Public Shareholding | 1.4% | 1,41,878 |
| Tanushree Kakani | Shareholding of Promoter and Promoter Group | 1.4% | 1,40,000 |
| Moneybee Investment Trust - Flyingbee Investment Fund | Public Shareholding | 1.3% | 1,27,363 |
| Svan Velocity Fund | Public Shareholding | 1.1% | 1,12,360 |
| Bhavi Dev Karvat | Public Shareholding | 1.1% | 1,12,360 |
| Laxmikavar Darda | Public Shareholding | 1.1% | 1,12,360 |
| Yash Surana | Public Shareholding | 1.1% | 1,12,360 |
| Prashant Shrimal | Shareholding of Promoter and Promoter Group | 1.1% | 1,12,360 |
| Anushka Munjal Shah | Public Shareholding | 1.1% | 1,12,360 |
| Gautam Chand Jain | Public Shareholding | 1.1% | 1,09,000 |
| Kirti Kumar Jain | Shareholding of Promoter and Promoter Group | 0.1% | 8,531 |
| Ghanshyam Jaju Huf | Shareholding of Promoter and Promoter Group | 0% | 2,200 |
| Ieshir Jaju | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Kirti Kumar Jain | 8,531 | 100% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Ghanshyam Jaju | Chairman(Non Exe)&Dir(Non-Ind) | 2025 |
| Mukund Kakani | Managing Director & CEO | 2025 |
| Mohit Jaju | Executive Director / Whole Time Director / CFO | 2025 |
| Dinesh Udpa | Independent Non Exe. Director | 2025 |
| Shilpa Bung | Independent Non Exe. Director | 2025 |
| Venkatesh Achanta | Company Sec. & Compli. Officer | 2025 |
| Mahindra Uday Bhalerao | Independent Non Exe. Director | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 20 | 10 | 10 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-14 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 14 | 0 | 14 |
| 2025 | 0 | 0 | 0 | 12 | 0 | 12 |
| 2025 | 0 | 0 | 0 | 1 | 0 | 1 |
Insider / Designated-Person Trades
1 recent disclosure(s)
Prashant ShrimalAcquisition · 1,12,360
Company Information
🌐 www.godavaridrugs.com ↗
📍 Mayfair 1-8-303-34, Sardar Patel Road, Secunderabad, Andhra Pradesh, 500003
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Shree Rajivlochan Oil Extraction Ltd.Piccadily Agro IndustriesChaman Lal Setia ExportsChandra Prabhu International Ltd.Kimia Biosciences LimitedHindustan Tin Works Ltd.Mukesh Babu Financial Services Ltd.Genus Power InfrastructuresKBS India LimitedPrabhhans Industries LimitedUgar Sugar WorksNRB Bearings Ltd.All “53” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search